Top

European Journal of Clinical Microbiology & Infectious Diseases

Published in:

01-08-2018 | Review

Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach

Authors: S. Moura, L. Cerqueira, A. Almeida

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 8/2018

Abstract

The fungus Aspergillus fumigatus is the main pathogenic agent responsible for invasive pulmonary aspergillosis. Immunocompromised patients are more likely to develop this pathology due to a decrease in the immune system’s defense capacity. Despite of the low occurrence of invasive pulmonary aspergillosis, this pathology presents high rates of mortality, mostly due to late and unspecific diagnosis. Currently, the diagnostic methods used to detect this fungal infection are conventional mycological examination (direct microscopic examination, histological examination, and culture), imaging, non-culture-based tests for the detection of galactomannan, β(1,3)-glucan and an extracellular glycoprotein, and molecular tests based on PCR. However, most of these methods do not detect the species A. fumigatus; they only allow the identification of genus Aspergillus. The development of more specific detection methods is of extreme importance. Fluorescent in situ hybridization-based molecular methods can be a good alternative to achieve this purpose. In this review, it is intended to point out that most of the methods used for the diagnosis of invasive pulmonary aspergillosis do not allow to detect the fungus at the species level and that fluorescence in situ hybridization-based molecular method will be a promising approach in the A. fumigatus detection.

McCormick A, Loeffler J, Ebel F (2010) Aspergillus fumigatus: contours of an opportunistic human pathogen. Cell Microbiol 12:1535–1543. https://doi.org/10.1111/j.1462-5822.2010.01517.x CrossRefPubMed

Dagenais TRT, Keller NP (2009) Pathogenesis of Aspergillus fumigatus in invasive Aspergillosis. Clin Microbiol Rev 22:447–465. https://doi.org/10.1128/CMR.00055-08 CrossRefPubMedPubMedCentral

Latgé JP (2001) The pathobiology of Aspergillus fumigatus. Trends Microbiol 9:382–389. https://doi.org/10.1016/S0966-842X(01)02104-7 CrossRefPubMed

Abad A, Victoria Fernández-Molina J, Bikandi J, Ramírez A, Margareto J, Sendino J et al (2010) What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis. Rev Iberoam Micol 27:155–182. https://doi.org/10.1016/j.riam.2010.10.003 CrossRefPubMed

Brand A, Alexandra (2012) Hyphal growth in human fungal pathogens and its role in virulence. Int J Microbiol 517529:2012. https://doi.org/10.1155/2012/517529 CrossRef

Warris A (2014) The biology of pulmonary aspergillus infections. J Inf Secur 69(Suppl 1):S36–S41. https://doi.org/10.1016/j.jinf.2014.07.011 CrossRef

Hage CA (2010) Breathing in America: diseases, progress, and hope. In: Schraufnage DE (ed) Fungal lung disease. American Thoracic Society, New York, pp 89–97

Costa CP, Gonçalves Silva D, Rudnitskaya A, Almeida A, Rocha SM (2016) Shedding light on Aspergillus niger volatile exometabolome. Sci Rep 6:27441. https://doi.org/10.1038/srep27441 CrossRefPubMedPubMedCentral

Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P et al (2014) Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 20:1163–1169. https://doi.org/10.3201/eid2007.140087 CrossRef

10.

Schmiedel Y, Zimmerli S (2016) Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia. Swiss Med Wkly 146:w14281. https://doi.org/10.4414/smw.2016.14281 PubMedCrossRef

11.

Cadena J, Thompson GR, Patterson TF (2016) Invasive Aspergillosis. Infect Dis Clin N Am 30:125–142. https://doi.org/10.1016/j.idc.2015.10.015 CrossRef

12.

Swoboda-Kopeć E, Sikora M, Piskorska K, Gołaś M, Netsvyetayeva I, Przybyłowska D et al (2016) Diagnosis of invasive pulmonary Aspergillosis. Adv Exp Med Biol. https://doi.org/10.1007/5584_2016_46

13.

Bernal-Martínez L, Alastruey-Izquierdo A, Cuenca-Estrella M (2016) Diagnostics and susceptibility testing in Aspergillus. Future Microbiol 11:315–328. https://doi.org/10.2217/fmb.15.140 CrossRefPubMed

14.

De Pauw B, Walsha TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T et al (2008) Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive. Clin Infect Dis 46:1813–1821. https://doi.org/10.1086/588660.Revised CrossRefPubMedPubMedCentral

15.

Sharma OP, Chwogule R (1998) Many faces of pulmonary aspergillosis. Eur Respir J 12:705–715. https://doi.org/10.1183/09031936.98.12030705 CrossRefPubMed

16.

Hope W, Walsh T, Denning D (2005) Laboratory diagnosis of invasive aspergillosis. Lancet Infect Dis 5:609–622. https://doi.org/10.1016/S1473-3099(05)70238-3 CrossRefPubMed

17.

Alexander BD, Pfaller MA (2006) Contemporary tools for the diagnosis and management of invasive mycoses. Clin Infect Dis 43:S15–S27. https://doi.org/10.1086/504491 CrossRef

18.

Muñoz P, Alcalá L, Sánchez Conde M, Palomo J, Yáñez J, Pelaez T et al (2003) The isolation of Aspergillus fumigatus from respiratory tract specimens in heart transplant recipients is highly predictive of invasive aspergillosis. Transplantation 75:326–329. https://doi.org/10.1097/01.TP.0000044358.99414.B8 CrossRefPubMed

19.

Zarrinfar H, Saber S, Kordbacheh P, Makimura K, Fata A, Geramishoar M et al (2012) Mycological microscopic and culture examination of 400 bronchoalveolar lavage (BAL) samples. Iran J Public Health 41:70–76PubMedPubMedCentral

20.

Nosari A, Anghilieri M, Carrafiello G, Guffanti C, Marbello L, Montillo M et al (2003) Utility of percutaneous lung biopsy for diagnosing filamentous fungal infections in hematologic malignancies. Haematol 88:1405–1409

21.

Hayden RT, Isotalo PA, Parrett T, Wolk DM, Qian X, Roberts GD et al (2003) In situ hybridization for the differentiation of Aspergillus, Fusarium, and Pseudallescheria species in tissue section. Diagn Mol Pathol Am J Surg Pathol 12:21–26CrossRef

22.

Latgé JP (1999) Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 12:310–350PubMedPubMedCentral

23.

Saghrouni F, Ben Youssef Y, Gheith S, Bouabid Z, Ben Abdeljelil J, Khammari I et al (2011) Twenty-nine cases of invasive aspergillosis in neutropenic patients. Médecine Mal Infect 41:657–662. https://doi.org/10.1016/j.medmal.2011.09.011 CrossRef

24.

Park SY, Kim S-H, Choi S-H, Sung H, Kim M-N, Woo JH et al (2010) Clinical and radiological features of invasive pulmonary aspergillosis in transplant recipients and neutropenic patients. Transpl Infect Dis 12:309–315. https://doi.org/10.1111/j.1399-3062.2010.00499.x CrossRefPubMed

25.

Milito MA, Kontoyiannis DP, Lewis RE, Liu P, Mawlawi OR, Truong MT et al (2010) Influence of host immunosuppression on CT findings in invasive pulmonary aspergillosis. Med Mycol 48:817–823. https://doi.org/10.3109/13693780903514872 CrossRefPubMed

26.

Xu S-C, Qiu L-H, Liu W-Y, Feng Y-L (2012) Initial computed tomography findings of invasive pulmonary aspergillosis in non-hematological patients. Chin Med J 125:2979–2985PubMed

27.

Greene RE, Schlamm HT, Oestmann J-W, Stark P, Durand C, Lortholary O et al (2007) Imaging findings in acute invasive pulmonary Aspergillosis: clinical significance of the halo sign. Clin Infect Dis 44:373–379. https://doi.org/10.1086/509917 CrossRefPubMed

28.

Park SY, Lim C, Lee S-O, Choi S-H, Kim YS, Woo JH et al (2011) Computed tomography findings in invasive pulmonary aspergillosis in non-neutropenic transplant recipients and neutropenic patients, and their prognostic value. J Inf Secur 63:447–456. https://doi.org/10.1016/j.jinf.2011.08.007 CrossRef

29.

Schalekamp S, van Ginneken B, van den Berk IAH, Hartmann IJC, Snoeren MM, Odink AE et al (2014) Bone suppression increases the visibility of invasive pulmonary Aspergillosis in chest radiographs. PLoS One 9:e108551. https://doi.org/10.1371/journal.pone.0108551 CrossRefPubMedPubMedCentral

30.

Miceli M, Maertens J (2015) Role of non-culture-based tests, with an emphasis on Galactomannan testing for the diagnosis of invasive Aspergillosis. Semin Respir Crit Care Med 36:650–661. https://doi.org/10.1055/s-0035-1562892 CrossRefPubMed

31.

Developing Diagnostic Solutions | OLM Diagnostics (2016). Available at: http://www.olmdiagnostics.com/. Acessed 26 December 2016

32.

Xavier MO, Araujo JSV, Aquino VR, Severo CB, Guazzelli LS, Severo LC et al (2013) Variability in Galactomannan detection by Platelia Aspergillus EIA™ according to the Aspergillus species. Rev Inst Med Trop Sao Paulo 55:145–147. https://doi.org/10.1590/S0036-46652013000300001 CrossRef

33.

Bölük G, Kazak E, Özkalemkaş F, Ener B, Akalin H, Ağca H et al (2016) Comparison of galactomannan, beta-D-glucan, and Aspergillus DNA in sera of high-risk adult patients with hematological malignancies for the diagnosis of invasive aspergillosis. Turk J Med Sci 46:335–342. https://doi.org/10.3906/sag-1408-100 CrossRefPubMed

34.

Tortorano AM, Esposto MC, Prigitano A, Grancini A, Ossi C, Cavanna C et al (2012) Cross-reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked Immunosorbent assay. J Clin Microbiol 50(3):1051. https://doi.org/10.1128/JCM.05946-11 CrossRefPubMedPubMedCentral

35.

Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT (2007) Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 59:113–115. https://doi.org/10.1016/j.diagmicrobio.2007.04.022 CrossRefPubMed

36.

Horn DL, Freifeld AG, Schuster MG, Azie NE, Franks B, Kauffman CA (2014) Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH alliance ® registry. Mycoses 57:652–658. https://doi.org/10.1111/myc.12212 CrossRefPubMed

37.

Vergidis P, Walker RC, Kaul DR, Kauffman CA, Freifeld AG, Slagle DC et al (2012) False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis. Transpl Infect Dis 14:213–217. https://doi.org/10.1111/j.1399-3062.2011.00675.x CrossRefPubMed

38.

Wheat LJ, Hackett E, Durkin M, Connolly P, Petraitiene R, Walsh TJ et al (2007) Histoplasmosis-associated cross-reactivity in the BioRad Platelia Aspergillus enzyme immunoassay. Clin Vaccine Immunol 14:638–640. https://doi.org/10.1128/CVI.00479-06 CrossRefPubMedPubMedCentral

39.

Fortún J, Martín-Dávila P, Alvarez ME, Norman F, Sánchez-Sousa A, Gajate L et al (2009) False-positive results of Aspergillus Galactomannan Antigenemia in liver transplant recipients. Transplantation 87:256–260. https://doi.org/10.1097/TP.0b013e31819288d5 CrossRefPubMed

40.

Zandijk E, Mewis A, Magerman K, Cartuyvels R (2008) False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clin Vaccine Immunol 15:1132–1133. https://doi.org/10.1128/CVI.00022-08 CrossRefPubMedPubMedCentral

41.

Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, De Carolis E et al (2011) Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 49:4273–4278. https://doi.org/10.1128/JCM.05026-11 CrossRefPubMedPubMedCentral

42.

Mori Y, Nagasaki Y, Kamezaki K, Takenaka K, Iwasaki H, Harada N et al (2010) High incidence of false-positive Aspergillus galactomannan test in multiple myeloma. Am J Hematol 85:449–451. https://doi.org/10.1002/ajh.21697 PubMedCrossRef

43.

Asano-Mori Y, Kanda Y, Oshima K, Kako S, Shinohara A, Nakasone H et al (2007) False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 61:411–416. https://doi.org/10.1093/jac/dkm463 CrossRefPubMed

44.

Lahmer T, Neuenhahn M, Held J, Rasch S, Schmid RM, Huber W (2016) Comparison of 1,3-β-d-glucan with galactomannan in serum and bronchoalveolar fluid for the detection of Aspergillus species in immunosuppressed mechanical ventilated critically ill patients. J Crit Care 36:259–264. https://doi.org/10.1016/j.jcrc.2016.06.026 CrossRefPubMed

45.

Boch T, Spiess B, Cornely OA, Vehreschild JJ, Rath PM, Steinmann J et al (2016) Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of. Clin Microbiol Infect 22:862–868. https://doi.org/10.1016/j.cmi.2016.06.021 CrossRefPubMed

46.

Salvatore CM, Chen TK, Toussi SS, DeLaMora P, Petraitiene R, Finkelman MA et al (2016) (1→3)-β-d-glucan in cerebrospinal fluid as a biomarker for Candida and Aspergillus infections of the central nervous system in pediatric patients. J Pediatric Infect Dis Soc 5:277–286. https://doi.org/10.1093/jpids/piv014 CrossRefPubMed

47.

Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ et al (2004) Beta-D-Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 39:199–205. https://doi.org/10.1086/421944 CrossRefPubMed

48.

Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S et al (2008) 1,3-beta-d-Glucan Antigenemia for early diagnosis of invasive fungal infections in Neutropenic patients with acute leukemia. Clin Infect Dis 46:878–885. https://doi.org/10.1086/527382 CrossRefPubMed

49.

Bhaskaran A, Kabbani D, Singer LG, Prochnow T, Bhimji A, Rotstein C et al (2017) (1,3) β-D-Glucan in Bronchoalveolar lavage of lung transplant recipients for the diagnosis of invasive pulmonary Aspergillosis. Med Mycol 55:173–179. https://doi.org/10.1093/mmy/myw052 CrossRefPubMed

50.

Angebault C, Lanternier F, Dalle F, Schrimpf C, Roupie A-L, Dupuis A et al (2016) Prospective evaluation of serum β-Glucan testing in patients with probable or proven fungal diseases. Open Forum Infect Dis 3:ofw128. https://doi.org/10.1093/ofid/ofw128 CrossRefPubMedPubMedCentral

51.

Koo S, Bryar JM, Page JH, Baden LR, Marty FM (2009) Diagnostic performance of the (1→3)-β-d-glucan assay for invasive fungal disease. Clin Infect Dis 49:1650–1659CrossRefPubMed

52.

Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A (2001) Elevation of blood (1 → 3 )-beta-D-glucan concentrations in hemodialysis patients. Nephron 89:15–19CrossRefPubMed

53.

Ogawa M, Hori H, Niiguchi S, Azuma E, Komada Y (2004) False-positive plasma (1-->3)-beta-D-glucan test following immunoglobulin product replacement in an adult bone marrow recipient. Int J Hematol 80:97–98CrossRefPubMed

54.

Hoenigl M, Koidl C, Duettmann W, Seeber K, Wagner J, Buzina W et al (2012) Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Inf Secur 65:588–591. https://doi.org/10.1016/j.jinf.2012.10.003 CrossRef

55.

Willinger B, Lackner M, Lass-Flörl C, Prattes J, Posch V, Selitsch B et al (2014) Bronchoalveolar lavage lateral-flow device test for invasive pulmonary Aspergillosis in solid organ transplant patients. Transplantation 98:898–902. https://doi.org/10.1097/TP.0000000000000153 CrossRefPubMed

56.

Prattes J, Lackner M, Eigl S, Reischies F, Raggam RB, Koidl C et al (2015) Diagnostic accuracy of the Aspergillus -specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients. Mycoses 58:461–469. https://doi.org/10.1111/myc.12343 CrossRefPubMed

57.

Thornton CR (2008) Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive Aspergillosis. Clin Vaccine Immunol 15:1095–1105. https://doi.org/10.1128/CVI.00068-08 CrossRefPubMedPubMedCentral

58.

Ohata A, Usami M, Horiuchi T, Nagasawa K, Kinoshita K (2003) Release of (1-->3)-beta-D-glucan from depth-type membrane filters and their in vitro effects on proinflammatory cytokine production. Artif Organs 27:728–735CrossRefPubMed

59.

Chong G-LM, van de Sande WWJ, Dingemans GJH, Gaajetaan GR, Vonk AG, Hayette M-P et al (2015) Validation of a new Aspergillus real-time PCR assay for direct detection of Aspergillus and azole resistance of Aspergillus fumigatus on bronchoalveolar lavage fluid. J Clin Microbiol 53:868–874. https://doi.org/10.1128/JCM.03216-14 CrossRefPubMedPubMedCentral

60.

Chong GM, van der Beek MT, von dem Borne PA, Boelens J, Steel E, Kampinga GA et al (2016) PCR-based detection of Aspergillus fumigatus Cyp51A mutations on bronchoalveolar lavage: a multicentre validation of the AsperGenius assay ® in 201 patients with haematological disease suspected for invasive aspergillosis. J Antimicrob Chemother 71:3528–3535. https://doi.org/10.1093/jac/dkw323 CrossRefPubMed

61.

Orsi CF, Bettua C, Pini P, Venturelli C, La Regina A, Morace G et al (2015) Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCR assays: comparison with conventional diagnostic tests. New Microbiol 38:75–84PubMed

62.

Zhao Y, Garnaud C, Brenier-Pinchart M-P, Thiébaut-Bertrand A, Saint-Raymond C, Camara B et al (2016) Direct molecular diagnosis of Aspergillosis and CYP51A profiling from respiratory samples of French patients. Front Microbiol 7:1164. https://doi.org/10.3389/fmicb.2016.01164 PubMedPubMedCentralCrossRef

63.

Sint D, Raso L, Traugott M (2012) Advances in multiplex PCR: balancing primer efficiencies and improving detection success. Methods Ecol Evol 3:898–905. https://doi.org/10.1111/j.2041-210X.2012.00215.x CrossRefPubMedPubMedCentral

64.

Markoulatos P, Siafakas N, Moncany M (2002) Multiplex polymerase chain reaction: a practical approach. J Clin Lab Anal 16:47–51CrossRefPubMed

65.

Cerqueira L, Azevedo NF, Almeida C, Jardim T, Keevil CW, Vieira MJ (2008) DNA mimics for the rapid identification of microorganisms by fluorescence in situ hybridization (FISH). Int J Mol Sci 9:1944–1960. https://doi.org/10.3390/ijms9101944 CrossRefPubMedPubMedCentral

66.

Silverman AP, Kool ET (2007) Oligonucleotide probes for RNA-targeted fluorescence in situ hybridization. Adv Clin Chem 43:79–115CrossRefPubMed

67.

Amann R, Fuchs BM, Behrens S (2001) The identification of microorganisms by fluorescence in situ hybridisation. Curr Opin Biotechnol 12:231–236CrossRefPubMed

68.

Muro MA (2005) Medical biomethods handbook. In: Walker JM, Rapley R (eds) Probe design, production, and applications. Humana press, Totowa, NJ, pp 13–23

69.

Nuovo GJ (2001) Co-labeling using in situ PCR: a review. J Histochem Cytochem 49:1329–1339. https://doi.org/10.1177/002215540104901101 CrossRefPubMed

70.

Kricka LJ (2002) Stains, labels and detection strategies for nucleic acids assays. Ann Clin Biochem 39:114–129. https://doi.org/10.1258/0004563021901865 CrossRefPubMed

71.

Shinozaki M, Okubo Y, Nakayama H, Mitsuda A, Ide T, Yamagata Murayama S et al (2009) Application of in situ hybridization to tissue sections for identification of molds causing invasive fungal infection. Jpn J Med Mycol 50:75–83CrossRef

72.

Myoken Y, Sugata T, Mikami Y, Murayama SY, Fujita Y (2008) Identification of Aspergillus species in oral tissue samples of patients with hematologic malignancies by In Situ hybridization: a preliminary report. J Oral Maxillofac Surg 66:1905–1912. https://doi.org/10.1016/j.joms.2008.01.053 CrossRefPubMed

73.

Montone KT (1994) In situ hybridization for ribosomal RNA sequences: a rapid sensitive method for diagnosis of infectious pathogens in anatomic pathology substrates. Acta Histochem Cytochem 27(6):601. https://doi.org/10.1267/ahc.27.601 CrossRef

74.

Hanazawa R, Murayama SY, Yamaguchi H (2000) In-situ detection of Aspergillus fumigatus. J Med Microbiol 49:285–290. https://doi.org/10.1099/0022-1317-49-3-285 CrossRefPubMed

75.

Bishop R (2010) Applications of fluorescence in situ hybridization (FISH) in detecting genetic aberrations of medical significance. Biosci Horizons 3:85–95. https://doi.org/10.1093/biohorizons/hzq009 CrossRef

76.

Moter A, Göbel UB (2000) Fluorescence in situ hybridization (FISH) for direct visualization of microorganisms. J Microbiol Methods 41:85–112CrossRefPubMed

77.

Amann R, Fuchs BM (2008) Single-cell identification in microbial communities by improved fluorescence in situ hybridization techniques. Nat Rev Microbiol 6:339–348. https://doi.org/10.1038/nrmicro1888 CrossRefPubMed

78.

Lehtola MJ, Loades CJ, Keevil CW (2005) Advantages of peptide nucleic acid oligonucleotides for sensitive site directed 16S rRNA fluorescence in situ hybridization (FISH) detection of Campylobacter jejuni, Campylobacter coli and Campylobacter lari. J Microbiol Methods 62:211–219. https://doi.org/10.1016/j.mimet.2005.02.009 CrossRefPubMed

79.

Frickmann H, Zautner AE, Moter A, Kikhney J, Hagen RM, Stender H et al (2017) Fluorescence in situ hybridization (FISH) in the microbiological diagnostic routine laboratory: a review. Crit Rev Microbiol 43:263–293. https://doi.org/10.3109/1040841X.2016.1169990 CrossRefPubMed

80.

Thatcher SA (2015) DNA/RNA preparation for molecular detection. Clin Chem 61:89–99. https://doi.org/10.1373/clinchem.2014.221374 CrossRefPubMed

81.

Smith JJ, Gunasekera TS, Barardi CRM, Veal D, Vesey G (2004) Determination of Cryptosporidium parvum oocyst viability by fluorescence in situ hybridization using a ribosomal RNA-directed probe. J Appl Microbiol 96:409–417CrossRefPubMed

82.

Li Z, Deutscher MP (2008) Analyzing the decay of stable RNAs in E. coli. Methods Enzymol 447:31–45. https://doi.org/10.1016/S0076-6879(08)02202-7 CrossRefPubMedPubMedCentral

83.

Harris DM, Hata DJ (2013) Rapid identification of bacteria and Candida using PNA-FISH from blood and peritoneal fluid cultures: a retrospective clinical study. Ann Clin Microbiol Antimicrob 12:2. https://doi.org/10.1186/1476-0711-12-2 CrossRefPubMedPubMedCentral

84.

Shakeel S, Karim S, Ali A (2006) Peptide nucleic acid (PNA)—a review. J Chem Technol Biotechnol 81:892–899. https://doi.org/10.1002/jctb.1505 CrossRef

85.

Sogaard M, Hansen DS, Fiandaca MJ, Stender H, Schonheyder HC (2007) Peptide nucleic acid fluorescence in situ hybridization for rapid detection of Klebsiella pneumoniae from positive blood cultures. J Med Microbiol 56(7):914. https://doi.org/10.1099/jmm.0.46829-0 CrossRefPubMed

86.

Forrest GN, Roghmann M-C, Toombs LS, Johnson JK, Weekes E, Lincalis DP et al (2008) Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy. Antimicrob Agents Chemother 52:3558–3563. https://doi.org/10.1128/AAC.00283-08 CrossRefPubMedPubMedCentral

87.

OpGen (2018). Available at: http://www.opgen.com/.Acessed 19 January 2018

88.

Machado A, Castro J, Cereija T, Almeida C, Cerca N (2015) Diagnosis of bacterial vaginosis by a new multiplex peptide nucleic acid fluorescence in situ hybridization method. PeerJ 3:e780. https://doi.org/10.7717/peerj.780 CrossRefPubMedPubMedCentral

89.

Cerqueira L, Fernandes RM, Ferreira RM, Oleastro M, Carneiro F, Brandão C et al (2013) Probe4pylori: a new kit for the rapid detection of H. pylori and associated clarithromycin resistance in gastric biopsies. Helicobacter 18:123–123

90.

Cerqueira LIM, Almeida CMF, Azevedo NFRPO, Vieira MJLC (2015) Peptide nucleic acid probe (PNA), kit and method for detection of Aspergillus fumigatus and applications thereof

Title: Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach
Authors: S. Moura
L. Cerqueira
A. Almeida
Publication date: 01-08-2018
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Clinical Microbiology & Infectious Diseases / Issue 8/2018
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-018-3251-5

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 8/2018

Factors impacting unbound vancomycin concentrations in neonates and young infants

Phenotypic detection of clinical isolates of Haemophilus influenzae with altered penicillin-binding protein 3

Detection of toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA

Serum antibody response to Chlamydia trachomatis TroA and HtrA in women with tubal factor infertility